Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
ID: 357270Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the funding opportunity titled "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts," aimed at establishing new population-based cancer epidemiology cohorts to address critical gaps in cancer etiology and survivorship. This initiative emphasizes the importance of engaging diverse and understudied populations, focusing on innovative recruitment strategies, community partnerships, and novel data collection methods over a five-year project period. The funding will be provided through a cooperative agreement, which requires substantial involvement from NIH, with applications due by March 1, 2025, and an anticipated earliest start date of February 28, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-186.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Cancer Institute (NCI) is soliciting applications for the funding opportunity titled "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts." This initiative aims to establish new population-based cancer epidemiology cohorts addressing gaps in knowledge related to cancer etiology and survivorship. The focus is on diverse and understudied populations, emphasizing critical methodological work. Key goals include reducing cancer risk and enhancing survivor quality of life through systematic research translation to interventions. Applications must demonstrate innovation in recruiting diverse populations, engaging community partners, and utilizing novel data collection methods within a five-year project period. Eligible organizations include higher education institutions, non-profits, and state and local governments. The funding mechanism is a cooperative agreement, necessitating substantial involvement from NIH. Applications must adhere to specific guidelines, including data management and sharing policies under NIH principles. The anticipated number of awards and budgets is contingent upon the NIH appropriations and quality of submissions. Applications are due by March 1, 2025, with an earliest start date of February 28, 2025. This initiative reflects a commitment to advancing cancer research by enhancing cohort diversity and methodological rigor. Participants are expected to engage in community partnerships throughout the research process.
    Similar Opportunities
    Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity titled "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)." This initiative aims to establish population-based cancer epidemiology cohorts to address critical knowledge gaps in cancer etiology and survivorship, particularly focusing on engaging diverse and underserved populations. The project will support methodological work necessary for cohort development, emphasizing community engagement and the validation of cancer outcomes linked to population-based registries. Interested applicants, including educational institutions, nonprofits, and local governments, must submit their proposals by February 28, 2025, and can find additional details at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity for research in established cancer epidemiology cohort studies under the U01 cooperative agreement mechanism. This initiative aims to support hypothesis-driven research utilizing data from cohorts that have achieved their initial recruitment goals, focusing on cohort maintenance, continuous follow-up, and resource sharing while addressing significant cancer control questions. The program encourages applications that leverage existing cohort data to explore understudied populations and cancer exposures, with no budget limits reflecting project needs and a maximum project duration of five years. Interested applicants must register with Grants.gov and adhere to NIH data-sharing policies, with the application deadline set for February 28, 2025. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAR-22-162.html.
    Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Research Opportunities in Established Cancer Epidemiology Cohort Studies" grant, aimed at supporting cancer epidemiology research through established cohort studies. This funding opportunity encourages hypothesis-driven research utilizing existing cohort data, with a focus on cancer risk reduction, morbidity, and improving the quality of life for cancer survivors. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofits, and governmental entities, with no specified budget limit, although budgets should reflect actual project needs for a maximum duration of five years. Interested parties must submit their applications electronically by February 28, 2025, and can find further details and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Basic Research in Cancer Health Disparities grant, aimed at supporting innovative research into the biological and genetic causes of cancer health disparities among diverse racial and ethnic populations. This grant encourages applications from a wide range of eligible applicants, including higher education institutions, nonprofits, and organizations serving underrepresented groups, with a focus on mechanistic studies, new methodologies, and the use of biospecimens to uncover cancer risk factors and develop prevention strategies. The application process opens on January 5, 2025, with the first submission deadline on February 5, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-243.html.
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)" aimed at investigating the biological and genetic mechanisms underlying cancer health disparities among diverse racial and ethnic populations. This funding initiative encourages innovative pilot studies that focus on identifying cancer risk factors, developing preventative strategies, and enhancing research methodologies, while fostering a multidisciplinary cohort dedicated to cancer health disparities research. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and tribal organizations, with a maximum funding amount of $275,000 available for a two-year project period. Interested parties should note that the application deadline is November 16, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-244.html for further details.
    Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem," aimed at supporting research projects that enhance cancer communication strategies. The initiative focuses on three key areas: the application of new cancer communication surveillance methods, the development of rapid pilot interventions, and the creation of multilevel communication models that emphasize bidirectional influences in cancer prevention and control. This funding, available through R21 exploratory/developmental grants, provides up to $275,000 for a maximum of two years, with applications due starting January 16, 2025. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)." This initiative aims to support applications that propose secondary data analysis and integration of existing datasets to better understand cancer risk factors and related outcomes, including survival and treatment responses. The program emphasizes the importance of leveraging clinical, genomic, lifestyle, and environmental data to address significant scientific questions in cancer research. Interested applicants can apply for grants with a maximum budget of $350,000 per year, with a project duration of up to five years. The application deadline is September 7, 2026, and further details can be obtained by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-095.html.
    Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the grant opportunity titled "Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)." This initiative aims to support research projects that explore innovative cancer communication strategies across three key areas: the development of new surveillance methods, the creation of rapid intervention strategies, and the formulation of multilevel communication models that highlight bidirectional influences. The opportunity is particularly relevant in the context of enhancing cancer prevention and control efforts in an increasingly digital landscape, addressing challenges such as misinformation and health disparities. Interested applicants can apply for funding up to $500,000 per year, with applications due by September 7, 2025. For further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at http://grants.nih.gov/grants/guide/pa-files/PAR-22-164.html.
    Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for epidemiologic research on emerging risk factors associated with liver cancer, specifically hepatocellular carcinoma and other subtypes. This initiative aims to investigate both novel and established biological, environmental, and social risk factors that contribute to liver cancer development in the United States, with a focus on understanding the interplay of these factors. The funding is available through the Research Project Grant (R01) mechanism for projects lasting up to five years, and applications are encouraged from a diverse range of eligible applicants, including educational institutions and community organizations. Interested parties should note that the application deadline is May 7, 2025, and can find more information at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem," aimed at supporting research projects that enhance cancer communication strategies. This initiative focuses on three key areas: the development of new cancer communication surveillance methods, the creation of rapid intervention strategies using innovative approaches, and the establishment of multilevel communication models that address the bidirectional influence of communication levels. The funding, which can provide up to $500,000 per year for a duration of up to five years, is intended to improve health outcomes related to cancer prevention and control, particularly in the context of addressing communication disparities and misinformation in the digital age. Interested applicants can find more information and guidelines for submission at the NIH Grants Information website, with the application period opening on January 5, 2025, and a submission deadline of September 7, 2025.